drugset / Trial / NCT00307619
An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness and tolerability of topiramate compared to placebo in patients with binge eating disorder receiving Cognitive Behavior Therapy (CBT)
Timeline
- Start
- 2003-11
- Primary completion
- —
- Completion
- 2005-04
Outcome
Met primary endpoint
paper Repeated-measures random regression analysis revealed a greater rate of weight reduction associated with topiramate over the course of treatment (p < .001) PMID 17915969 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 200 mg | — |